Kübra Yeter-Aydeniz, a postdoctoral researcher, was recently named the Turkish Women in Science group’s “Scientist of the Week.”
Experts at the Department of Energy’s Oak Ridge National Laboratory are now offering short-term technical and scientific assistance to entities working to combat the coronavirus through the COVID-19 Technical Assistance Program, an initiative of DOE’s Office of Technology Transitions.
Researchers at ORNL used quantum optics to advance state-of-the-art microscopy and illuminate a path to detecting material properties with greater sensitivity than is possible with traditional tools.
The Department of Energy has selected Oak Ridge National Laboratory to lead a collaboration charged with developing quantum technologies that will usher in a new era of innovation.
Oak Ridge National Laboratory researchers have developed artificial intelligence software for powder bed 3D printers that assesses the quality of parts in real time, without the need for expensive characterization equipment.
Oak Ridge National Laboratory researchers have developed a machine learning model that could help predict the impact pandemics such as COVID-19 have on fuel demand in the United States.
An all-in-one experimental platform developed at Oak Ridge National Laboratory’s Center for Nanophase Materials Sciences accelerates research on promising materials for future technologies.
Joe Hagerman, ORNL research lead for buildings integration and controls, understands the impact building technology innovations can have during times of crisis. Over a decade ago, he found himself in the middle of one of the most devastating natural disasters of the century, Hurricane Katrina.
ORNL researchers have developed an intelligent power electronic inverter platform that can connect locally sited energy resources such as solar panels, energy storage and electric vehicles and smoothly interact with the utility power grid.
A team led by Dan Jacobson of Oak Ridge National Laboratory used the Summit supercomputer at ORNL to analyze genes from cells in the lung fluid of nine COVID-19 patients compared with 40 control patients.